| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.3 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |